Treatment of Urinary Tract Infection: Clinical and Economic Considerations

PharmacoEconomics

Volumn 9, Issue 4, 1996, Pages 295-306

  Plumridge, Richard J ^a   Golledge, Clayton L ^b  

^a FREMANTLE HOSPITAL   (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFALEXIN; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; NITROFURANTOIN; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; HEALTH CARE COST; HUMAN; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION;

ADULT; ANTI-INFECTIVE AGENTS, URINARY; CHILD; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HUMANS; RECURRENCE; URINARY TRACT INFECTIONS;

EID: 0029883565     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609040-00003     Document Type: Review

References (67)

1. Gould JC. The comparative bacteriology of acute and chronic urinary lract infections. In: O'Grady DF, Brumfitt W, editors. Urinary tract infection. London: Oxford University Press, 1968: 43-50
2. Turck M, Stamm WE. Nosocomial infection of the urinary tract. Am J Med 1981; 70: 651-4
3. Stull TL, Lipuma JJ. Epidemiology and natural history of urinary tract infections in children. Med Clin North Am 1991; 75: 287-97
4. Smellie JM. Reflections on thirty years of treating children with urinary tract infections. J Urol 1991; 146: 665-8
5. Baldassarre JS, Kaye D. Special problems of urinary tract infection in the elderly. Med Clin North Am 1991; 75: 375-90
6. McCracken GH. Diagnosis and management of acute urinary tract infections in infants and children. Paediatr Infect Dis 1987; 6: 107-12
7. Edwards D, Normand ICS, Prescod N, et al. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. BMJ 1977; 2: 285-8
8. Kemper KJ. The case against screening urinanalysis for asymptomatic bacteria in children. Am J Dis Child 1992; 146: 343-6
9. Ronald AR, Patrillo AS. The natural history of urinary infection in adults. Med Clin North Am 1991; 75: 299-312
10. Boscia JA, Abruteyn E, Kaye D. Asymptomatic bacteriuria in elderly patients: treat or do not treat? Ann Intern Med 1987; 106: 764-6
11. Nordenstam GR, Brandenberg CA, Oden AS, et al. Bacteriuria and mortality in an elderly population. N Engl J Med 1986; 314: 1152-6
12. Tastame Y, Degovio N, Palmer JM. The localisation and treatment of urinary tract infections: the role of bactericidal urine levels as opposed to serum levels. Medicine 1965; 44: 1-36
13. Norrby SR. Short term treatment of uncomplicated urinary tract infections in women. Rev Infect Dis 1990; 12: 458-67
14. Johnson J, Stamm W. Diagnosis and treatment of acute urinary tract infection. Infect Dis Clin North Am 1987; 1: 77-91
15. Saginur R, Nicolle LE. Single dose compared with three day norfloxacin treatment of uncomplicated urinary tract infection in women. Arch Intern Med 1992; 152: 1233-7
16. Sherbotie JR, Cornfield D. Management of urinary tract infections in children. Med Clin North Am 1991; 75: 327-38
17. Wong ES, McKevitt M, Running K, et al. Management of recurrent urinary tract infection with patient administered single dose therapy. Ann Intern Med 1985; 102: 302-7
18. Vosti K. Recurrent urinary tract infection: prevention by prophylactic antibiotics after sexual intercourse. JAMA 1975; 231: 934-40
19. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: diagnosis and treatment. Infect Dis Clin North Am 1987; 1: 793-806
20. Brumfitt W, Smith GW, Hamilton-Miller JMT, et al. A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary tract infections J Antimicrob Chemother 1985; 16: 111-20
21. Hooton TM, Stamm WE. Management of acute and complicated urinary tract infections in adults. Med Clin North Am 1991; 75: 339-57
22. Turck M, Ronald AR, Peterdorf RG. Relapse and reinfection in chronic bacteriuria. N Engl J Med 1968; 2: 427-8
23. MacDonald TM. The economic evaluation of antibiotic therapy: relevance to urinary tract infection. J Antimicrob Chemother 1994; 33 Suppl. A: 137-45
24. Patton JP, Nash DB, Abrutyn E. Urinary tract infection: economic considerations. Med Clin North Am 1991; 75: 495-513
25. Kolbeck JC, Padgett RA, Estevez EG, et al. Bioluminescence screening for bacteriuria. J Clin Microbiol 1985; 21: 527-30
26. Pezzlo M. Detection of urinary tract infections by rapid methods. Clin Microbiol Rev 1988; 1: 268-80
27. Nash DB, Goldfarb NI. Exploring resource use in high-cost versus low-cost care: the pharmaceutical example. DRG Monit 1987; 4: 1-8
28. Graham NMH. Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract. PharmacoEconomics 1994; 5 Suppl. 2: 1-10
29. MacDonald TM, Collins D, McGilchrist MM, et al. The utilisation and economic evaluation of antibiotics prescribed in primary care. J Antimicrob Chemother 1995; 35: 191-204
30. Scheife RT, Cox CE, McCabe RE, et al. Norfloxacin vs best parenteral therapy in treatment of moderate to serious, multiply-resistant, nosocomial urinary tract infections: a pharmacoeconomic analysis. Urology 1988; 32 (3 Suppl.): 24S-30S
31. Gladen HE, Jackson JD, Jordan JT. Antibiotics, DRGs, and the personal computer: simple techniques to estimate true cost. Infect Surg 1986; 5: 559-67
32. Gladen HE. Computer modelling antibiotic therapy costs: impact of therapeutic range. Drugs 1988; 35 Suppl. 2: 208-13
33. Atkinson HC, Chambers ST, MeGinlay AM. Antibiotic therapy costs. N Z Med J 1989; 102: 409-11
34. Plumridge RJ. Cost comparison of intravenous antibiotic administration. Med J Aust 1990; 153: 516-8
35. Cooke J, Cairns CJ, Tillotson GS, et al. Comparative clinical, microbiological, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials. Ann Pharmacother 1993; 27: 785-9
36. Dydek GJ, Souney PF, Matthews SJ. DUE of ciprofloxacin in the treatment of urinary tract infections in hospitalised patients. Hosp Formul 1992; 27: 185-91
37. Gladen HE. Evaluating the cost-effectiveness of treatment with third-generation cephalosporins. Diagn Microbiol Infect Dis 1992; 15: 99-105
38. Rapp RP, Bannon CL, Bivins BA. The influence of dose frequency and agent toxicity on the cost of parenteral antibiotic therapy. Drug Intell Clin Pharm 1982; 16: 935-8
39. Eisenberg JM, Koffer H, Glick HA, et al. What is the cost of nephrotoxicity associated with aminoglycosides? Ann Intern Med 1987; 107: 900-9
40. Newhouse JG, Paul VM, Waugh NA, et al. Reducing IV waste to under 2.25 percent Hosp Pharm 1988; 23: 241-7
41. Salberg DJ, Newton RW, Leduc DT. Cost of wastage in a hospital intravenous admixture program. Hosp Formul 1984; 19: 375-8
42. Cousins DH, Lee M, Stanaway M, et al. Implementation and evaluation of a centralised IV additive service for antibiotic injections. Pharm J 1989; 242 Suppl.: 14S-6S
43. Kerr JR, Barr JG, Smyth ET, et al. Technique for calculation of the true costs of antibiotic therapy. Eur J Clin Microbiol Infect Dis 1992; 11: 823-7
44. Sandborn WJ, Forland SC, Cutler RE, et al. Pharmacokinetics and pharmacodynamics of oral and intravenous cimetidine in seriously ill patienta. J Clin Pharmacol 1990; 30: 568-71
45. Frighetto L, Nickoloff D, Martinusen SM, et al. Intravenous-to-oral stepdown program: four years of experience in a large teaching hospital. Ann Pharmacother 1992; 26: 1447-51
46. Guay DR, Peterson PK, Stein DJ, et al. Cost comparison of ciprofloxacin versus cefamandole. DICP Ann Pharmacother 1989; 23: 92-3
47. Parker SE, Davey PG. Pharmacoeconomics of intravenous drug administration. PharmacoEconomics 1992; 1: 103-15
48. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 182: 182-205
49. Haley RW, Culver DH, White JW, et al. The nationwide nosocomial infection rate, a new need for vital statistics. Am J Epidemiol 1985; 121: 159-67
50. Centers for Disease Control. National nosocomial infections study report. Atlanta (GA): US Department of Health and Human Services, Public Health Service, 1979 Nov
51. Haley RW, Crossley BB, Von Allmen SD, et al. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981; 70: 51-8
52. Platt R, Polk BF, Murdock B, et al. Mortality associated with nosocomial urinary tract infection. N Engl J Med 1982; 307: 637-42
53. Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol 1980; 124: 646-8
54. Penin GB, Ehrenkranz NJ. Priorities for surveillance and cost-effective control of post-operative infection. Arch Surp 1988; 123: 1305-8
55. Rutledge KA, McDonald HP. Costs of treating simple nosocomial urinary tract infection. Urology 1985; 26 Suppl.: 24-6
56. Scheckler WE. Hospital costs of nosocomial infections: a prospective three month study in a community hospital. Infect Control 1980; 1: 150-2
57. Rubinstein E, Green M, Modan M, et al. The effects of nosocomial infections on the length and costs of hospital stay. J Antimicrob Chemother 1982; 9: 93-9
58. Fry DE. Discussion accompanying Penin GB, Ehrenkranz NJ. Priorities for surveillance and cost-effective control of post-operative infection. Arch Surg 1988; 123: 1305-8
59. Miller PJ, Farr BM, Gwaltney JM. Economic benefits of an effective infection control program: case study and proposal. Rev Infect Dis 1989; 11: 284-8
60. Sencer DJ, Axnick NW. Utilisation of cost benefit analysis in planning prevention programs. Acta Med Scand 1975; 576 Suppl.: 123-8
61. Platt R, Polk BF, Murdock B, et al. Prevention of catheter-associated urinary tract infection: a cost-benefit analysis. Infect Control Hosp Epidemiol 1989; 10: 60-4
62. Garibaldi RA, Mooney BR, Epstein BJ, et al. An evaluation of daily bacteriological monitoring to identify preventable episodes of catheter-associated urinary tract infection. Infect Control 1982; 3: 466-70
63. Hale RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947-59
64. Hartslein AI, Garger SB, Ward TT, et al. Nosocomial urinary tract infection: a prospective evaluation of 108 catheterised patients. Infect Control 1981; 2: 380-6
65. 2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomised controlled study. Infect Control 1985; 6: 263-6
66. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 793-803
67. Warren JW. Clinical advances in urinary tract infections Curr Opin Infect Dis 1995; 8: 43-8